Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
FDA Directed to Streamline Approval Pathways for Plant-Based Infant Formulas, Positioning Else Nutrition to Capitalize on Legislative Momentum and Rising Consumer Demand
VANCOUVER, BC, July 22, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the"Company"), a global leader in wholefood, plant-pased childhood nutrition for babies, toddlers, children and adults, today applauds the U.S. House of Representatives Committee on Appropriations for the full-committee passage of the FY2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill. This landmark legislation includes vital language recognizing the importance of expanding access to alternative infant formulas—specifically plant-based, non-soy, and non-dairy formulations—for a growing number of American families.
The accompanying report directs the U.S. Food and Drug Administration (FDA) to streamline approval pathways for small domestic manufacturers and calls for formal regulatory guidance around non-dairy, non-soy plant-based formulas. These are critical for infants with allergies, intolerances, or sensitivities to traditional ingredients—as well as for families seeking nutritional alternatives aligned with health, lifestyle, or ethical values.
"This marks a turning point for American families and for Else Nutrition," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "For too long, parents have had to choose between limited formula options that may not meet their child's needs. This legislative milestone signals that change is coming—toward a more inclusive and diversified infant formula landscape. We commend Congress for recognizing this urgent need and taking action that we believe will benefit families for generations to come."
Although these types of advanced formulas have gained traction in global markets, regulatory delays have historically constrained innovation in the U.S. market. The recently advanced legislative language is a strong signal to the FDA to establish clear, actionable guidance that can accelerate the availability of safe, effective, and scientifically backed alternatives.
The report also highlights the Operation Stork Speed initiative, part of the Administration's broader effort to fast-track innovation in the infant formula space. By elevating plant-based, non-dairy, non-soy formulations as a key component of this initiative, the legislation reinforces the national commitment to nutritional accessibility and product diversity.
While additional legislative steps remain—including passage by the full House—the inclusion of this language in the committee's final report is a powerful indication of Congressional momentum. Though report language is non-binding, it frequently shapes agency priorities, resource allocation, and the pace at which new regulatory frameworks are developed.
For Else Nutrition, the implications are clear: the path to broader U.S. market access is becoming more defined.
"This is the clearest signal yet that U.S. policymakers are aligned with what we at Else have long championed—that every child deserves access to safe, effective, and nutritionally complete formula options," Yitzhak added. "We look forward to supporting this important public health mission by working with the FDA and other federal partners to help bring innovative solutions to more families, more quickly."
DISCLAIMERS
This grassroots lobbying effort is a statement of issue advocacy and does not require disclosure under the Lobbying Disclosure Act. This is not an electioneering statement, and this message has not been coordinated with any political parties or candidates. This message is paid for by Else Nutrition and is intended for only a "restricted class" of stockholders and administrators of the company. Whereas this is an instance of grassroots lobbying, Else Nutrition's engaged lobbying principals file disclosures required under the Lobbying Disclosure Act for direct lobbying services on behalf of the company.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
"2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit
#1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
"Best Dairy Alternative" Award 2021 at World Plant-Based Expo
Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon
TSX
Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
SOURCE Else Nutrition Holdings Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
36 minutes ago
- Cision Canada
Intellistake Technologies Corp. Announces OTCQB Quotation
VANCOUVER, BC, Aug. 4, 2025 /CNW/ - Intellistake Technologies Corp. (CSE: ISTK) (OTCQB: ISTKF) (FSE: E41) (" Intellistake" or the" Company") is pleased to announce that its common shares have commenced trading on the OTCQB Market under the symbol "ISTKF". The Company's common shares will continue to trade on the Canadian Securities Exchange under the symbol"ISTK". The Company expects that the quotation on OTCQB will provide greater visibility and convenience of trading for US investors, resulting in enhanced liquidity and greater reach. OTCQB is a premier and established market for entrepreneurial and development-stage companies to trade in the United States. It is recognized by the United States Securities and Exchange Commission as an established public market providing public information for analysis and value of securities. OTCQB offers companies the opportunity to build their visibility, expand their liquidity and diversify their shareholder base on an established public market. Investors in the United States can learn more about the Company on its OTC Markets profile page located via the following URL: About Intellistake: Intellistake's mission is to provide traditional investors with regulated access to the intersection of artificial intelligence and blockchain technology, through familiar stock exchange mechanisms. The Company eliminates technical barriers including digital asset wallet management and private key security, while addressing the institutional access gap that has historically limited participation to celebrities and venture capitalists with early access to private AI companies. For additional information on Intellistake, please refer to Intellistake has very recently completed the change of business transaction and is presently at an early stage of development. It has not yet acquired any digital assets, nor has it commenced validator and staking operations. It has also not yet developed any AI technology solutions. With the change of business completed it will now commence the execution of the business plan described in the Listing Statement dated June 30, 2025 and filed with the Canadian Securities Exchange and on SEDAR+ at It is important to note that as with any investment there are risks including that digital assets remain an emerging assets class with government regulation still under development, there has been significant volatility in digital assets and their value can decline rapidly, historical performance of digital assets in not indicative of their future performance and global digital asset demand may not continue to increase due to global financial conditions and other factors. Intellistake is a start-up that does not have the same access to capital as other larger more established companies. Please refer to "Cautionary Note Regarding Forward-Looking Information" and the Listing Statement for additional details on the risks associated with the Company's business. Cautionary Note Regarding Forward-Looking Information This news release contains "forward-looking information" concerning anticipated developments and events related to the Company that may occur in the future. Forward looking information contained in this news release includes, but is not limited to, all statements in respect of the Company's growth and development, the operations and business segments of the Company; details of planned validator operations, and expectations regarding the market for digital currencies, tokenization and decentralized AI. In certain cases, forward-looking information can be identified by the use of words such as "expects", "intends", "anticipates" or variations of such words and phrases or state that certain actions, events or results "may", "would", or "might" suggesting future outcomes, or other expectations, assumptions, intentions or statements about future events or performance. Forward-looking information contained in this news release is based on certain assumptions regarding, among other things, the Company will continue to have access to financing until it achieves profitability; the technology and blockchain industries in which the Company intends to focus its business in will grow at the rate and in the manner expected; the ability to attract qualified personnel; the success of market initiatives and the ability to grow brand awareness; the ability to distribute Company's services; the Company creates strategies to mitigate risks associated with cryptocurrency price fluctuations; the Company remains compliant with all applicable laws and securities regulations; the Company engages and collaborates with local experts, as necessary, to address jurisdiction-specific matters and ensures compliance with foreign regulations to avoid penalties; the Company addresses any potential cybersecurity threats promptly and effectively; and the ability to successfully deploy the new business strategy as a result of the change of business. While the Company considers these assumptions to be reasonable, they may be incorrect. Forward looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results to be materially different from any future results expressed by the forward-looking information. Such factors include risks related to general business, economic and social uncertainties; failure to raise the capital necessary to fund its operations; inability to create strategies to mitigate the risks associated with cryptocurrency price fluctuations; the costs of regulation in the digital asset industries increase to the extent that the Company is no longer generating sufficient returns for shareholders; failure to promptly and effectively address cybersecurity threats; insufficient resources to maintain its operations on a competitive basis; and the actual costs, timing and future plans differs expectations; legislative, environmental and other judicial, regulatory, political and competitive developments; the inherent risks involved in the cryptocurrency and general securities markets; the Company may not be able to profitably liquidate its current digital currency inventory, or at all; a decline in digital currency prices may have a significant negative impact on the Company's operations; the volatility of digital currency prices; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties; delay or failure to receive regulatory approvals; failure to attract qualified personnel, labour disputes; and the additional risks identified in the "Risk Factors" section of the Company's filings with applicable Canadian securities regulators. Although the Company has attempted to identify factors that could cause actual results to differ materially from those described in forward-looking information, there may be other factors that cause results not to be as anticipated. Readers should not place undue reliance on forward-looking information. The forward-looking information is made as of the date of this news release. Except as required by applicable securities laws, the Company does not undertake any obligation to publicly update forward-looking information. SOURCE Intellistake Technologies Corp.
Japan Forward
7 hours ago
- Japan Forward
Do Not Open Japan-US Trade Deal to Distorted Interpretation
このページを 日本語 で読む A trade deal was concluded by the Shigeru Ishiba administration and the Donald Trump administration. But, were the provisions of the agreement actually finalized? It is difficult to dispel doubts on that score. There are stark differences in how the Japanese and US sides explain provisions on new investment in the United States. This is a cause for concern in the actual implementation of the agreement. One of the main pillars of the Japan-US agreement sets reciprocal tariffs and auto tariffs the US imposes on Japanese imports at 15%. However, no written agreement has been drawn up. Isn't that the cause of the differences in perception between the two sides? Prime Minister Shigeru Ishiba should have spoken directly with President Trump immediately after the agreement was reached to share his views. His failure to do so has created a major problem. If things continue as they are, it is possible that the US side will try to force its own interpretation on Japan. If that were to happen, Japan's national interest might well suffer damage. The Prime Minister and Minister for Economic Revitalization Ryosei Akazawa should clarify the reasons for these differing perceptions during the extraordinary Diet session that convened on August 1. They have a duty to explain to the satisfaction of the Japanese people that the agreement will be appropriately implemented. US President Donald Trump speaks at the White House on July 31 (©Reuters via Kyodo) Regarding Japanese investment in the United States, Trump posted on social media that Japan will invest $550 billion USD (approximately ¥80 trillion JPY) in the United States. Furthermore, he said, the US will receive 90% of the profits. In response, the Japan side has explained that the $550 billion in question is actually the upper limit for investments, loans, and loan guarantees. Of this, the "90%" of the profits the US would stand to make from the deal are from investment projects. That amounts to just 1% to 2% of the $550 billion, according to Akazawa. As for the issue of rice, the US side claims that Japan's imports of American rice will increase by 75%. However, Japan has not provided any specific details. Won't this really amount to sacrificing Japan's agricultural sector? US Treasury Secretary Scott Bessent has also declared that he intends to review Japan's compliance with the agreement quarterly. He has further threatened that tariffs will be raised to 25% if Trump is not satisfied. That would provide leeway for Trump to unilaterally scrap the agreement. The lack of a joint document sharing a mutual understanding of what the agreement entails has left a legacy of problems. The Japanese side prioritized an early conclusion to the talks. That allowed the delay of the time-consuming task of hammering out a written agreement. Their excuse was to avoid a situation where an agreement could not be reached by the Trump-imposed deadline of August 1. On that date, Trump's reciprocal tariffs on Japan were scheduled to rise to 25%. Even if that is true, it will end up counterproductive if the agreement comes to be distorted by the US interpretation. Above all, the Ishiba government should urge the Trump administration to quickly align their respective views. We should realize that, unless both sides share a mutual understanding, economic uncertainty from Trump's tariffs will not dissipate. Author: Editorial Board, The Sankei Shimbun このページを 日本語 で読む
The Province
7 hours ago
- The Province
The two ways Trump's tariffs on Canada could collapse — despite his fight to keep them
The courts are considering whether they're even legal under U.S. law, and the American economy has yet to feel the pain of higher prices Dubbing it "Liberation Day," U.S. President Donald Trump announces his plan to enact sweeping new reciprocal tariffs worldwide, on April 2, 2025. Photo by Brendan Smialowski/AFP via Getty Images/File WASHINGTON, D.C. — Time's up. On Friday, U.S. President Donald Trump raised the tariff rate on Canadian goods not covered under the Canada-United States-Mexico Agreement (CUSMA) from 25 to 35 per cent, saying they 'have to pay a fair rate.' The White House claims it's because of Canada's failure to curb the 'ongoing flood of fentanyl and other illicit drugs.' U.S. Customs and Border Protection (CBP) data, however, show that fentanyl seizures from Canada make up less than 0.1 per cent of total U.S. seizures of the drug; most smuggling comes across the Mexican border. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Exclusive articles by top sports columnists Patrick Johnston, Ben Kuzma, J.J. Abrams and others. Plus, Canucks Report, Sports and Headline News newsletters and events. Unlimited online access to The Province and 15 news sites with one account. The Province ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles and comics, including the New York Times Crossword. Support local journalism. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Exclusive articles by top sports columnists Patrick Johnston, Ben Kuzma, J.J. Abrams and others. Plus, Canucks Report, Sports and Headline News newsletters and events. Unlimited online access to The Province and 15 news sites with one account. The Province ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles and comics, including the New York Times Crossword. Support local journalism. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors But the future of Trump's policy also rests on shaky ground, and the tariffs could come crashing down even if Canada can't reach a deal at some point. Imposed through a controversially declared 'national emergency' under the International Emergency Economic Powers Act (IEEPA), the tariffs come with essentially three paths for relief to Canadian exporters and their American customers: the courts and the economy. And there's always the wildcard: that the president changes his mind. Without relying on that, National Post looks at two very possible ways out of all this: The courts: There is a big question hanging over whether Trump's tariffs are even legal under the U.S. Constitution, which gives Congress powers over trade. Trump has bypassed that by claiming he's using presidential IEEPA emergency powers. This advertisement has not loaded yet, but your article continues below. On Thursday, the Washington, D.C.-based Federal Circuit Court of Appeals convened an en banc hearing for oral arguments in challenges to Trump's use of IEEPA. The 11 judges questioned whether the law meant for sanctioning adversaries or freezing assets during emergencies grants Trump the power to impose tariffs, with one judge noting, 'IEEPA doesn't even mention the word 'tariffs.'' The White House, meanwhile, says the law grants the president 'broad and flexible' emergency powers, including the ability to regulate imports. 'Based on the tenor and questions of the arguments, it appears that the challengers have the better odds of prevailing,' Thomas Berry, the CATO Institute's director of the Robert A. Levy Center for Constitutional Studies, said in a statement. 'Several judges peppered the government's attorney with skeptical questions about why a broad term in IEEPA like 'regulate importation' should be read to allow the president to unilaterally impose tariffs.' Essential reading for hockey fans who eat, sleep, Canucks, repeat. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. Trump's lawyers claim his executive order provides the justifications for the tariffs — in Canada's case, fentanyl. But Berry said 'those justifications would not matter if IEEPA simply does not authorize tariffs in the first place. That is the cleanest and simplest way to resolve this case, and it appears that the Federal Circuit may be leaning toward that result.' A decision is expected this month, and if it's a resounding push back from the judges' panel, said Andrew Hale, a senior policy analyst at Heritage Foundation, the Supreme Court may not even take up the case. If so, he says, 'these Liberation Day tariffs and everything that's been imposed under emergency legislation, IEEPA, that all evaporates.' At that point, the White House would not be able to declare across-the-board tariffs against countries. Instead, it would have to rely on laws allowing tariffs to be imposed on specific products that are found to threaten U.S. national security, like those currently imposed on Canadian steel and lumber. This advertisement has not loaded yet, but your article continues below. The economy: The other path to tariff relief is through economic pressure. If Americans start to see higher prices and economic uncertainty, and push back at the ballot box — or threaten to do so — it could force Trump to reverse course. The most recent figures show that U.S. inflation, based on the Consumer Price Index, hit around 2.7 per cent in July. That's a slight rise, fuelled by rising prices for food, transportation and used cars. But it's still close to the Federal Reserve target of two per cent. U.S. unemployment rose slightly to 4.2 per cent in July, while far fewer jobs were created than expected, and consumer confidence rose two points but is still several points lower than it was in January. Overall, most economists agree that risks of a U.S. recession over the next 12 months are relatively low, but skepticism over growth remains high. 'Our outlook is for slower growth in the U.S., but no recession,' said Gus Faucher, chief economist of The PNC Financial Services Group. He notes that the 'tariffs are going to be a drag' because they are a tax increase on imports. This advertisement has not loaded yet, but your article continues below. Economists have said price inflation from tariffs is not yet being felt in the U.S. but believe it's inevitable. 'Trump's tariff madness adds a great deal to the risks of a recession,' said Steven Hanke, professor of applied economics at Johns Hopkins University who served on President Ronald Reagan's Council of Economic Advisors. 'With tariffs, Americans are going to be paying a big new beautiful sales tax on goods and services imported into the U.S., and taxes slow things down. Taxes don't stimulate.' It is surprising that higher U.S. prices haven't happened yet, said Jonathan Gruber, chairman of the economics department at the Massachusetts Institute of Technology. But he explained that it's likely a reflection of the duration of contracts and the fact that import sellers haven't yet put up prices — 'because they were hoping it wouldn't be real, like they'd wake up from this nightmare.' This advertisement has not loaded yet, but your article continues below. 'I think we start to see the effect on prices by the end of the year,' said Gruber. The trouble for Canada, however, is that the Canadian economy is starting from a much weaker position, with higher unemployment, lower consumer confidence, and a slowing GDP, on top of the trade tensions. So, trying to wait things out for the U.S. to feel the pinch will be even more painful for Canadians. And any American downturn will also reverberate north. 'As Uncle Sam goes, so goes Canada,' said Hanke. Gruber agrees with that, but with a caveat. 'It's all bad in the short run and good in the long run,' he says. He believes the U.S. is 'weak and getting weaker' and that Canada should start taking advantage of how the U.S. is making opportunities for other countries to invest in themselves. This advertisement has not loaded yet, but your article continues below. 'We're not investing in our future. We're killing our education. We're killing our research. We're not allowing in immigrants,' he said, explaining the weakening of the U.S. economy. 'We're basically setting the stage for long-run economic slower growth.' Meanwhile, China is doubling down on investment, research and other longer-term policies. 'Canada and other countries need to do the same,' Gruber said. And as for when a backlash could lead to a reversal in the U.S., Gruber points to two factors. 'It's got to be high inflation, and Trump's opponents need to make sure that the voters understand that's Trump's fault.' National Post tmoran@ Read More Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our newsletters here. News News Tennis Columnists Vancouver Canucks
